Abstract-Nitric oxide (NO) is a potent inhibitor of thrombin-induced increase in cytoplasmic free Ca 2ϩ concentration and aggregation in platelets, but the precise mechanism of this inhibition is unclear. To measure Ca 2ϩ /Mn 2ϩ influx in intact platelets and to monitor Ca 2ϩ uptake into the stores in permeabilized platelets, fura-2 was used. 4 -6 Similar to other types of nonexcitable cells, 7 agonist-activated Ca 2ϩ influx in platelets is thought to be capacitative in nature, being also activated by passive store depletion with an inhibitor(s) of sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPase (SERCA), thapsigargin (TG) or 2,5-di-(tert-butyl)-1,4-benzohydroquinone (BHQ). 8 -11 Nitric oxide (NO), a potent inhibitor of thrombin-activated platelet aggregation, 12,13 is known to decrease Ca 2ϩ cyt that is raised by agonists, 14 although the mechanism is not well defined. It has been shown that NO inhibits thrombin-and IP 3 -stimulated Ca 2ϩ release from internal stores in intact 15 and permeabilized platelets. 16, 17 However, it is still unclear whether NO also inhibits capacitative cation influx. Brune et al 17 found a significant inhibitory effect of the NO donor, sodium nitroprusside, on Mn 2ϩ influx in TG-treated platelets. In contrast, Okamoto et al 18 did not find an effect of the NO donor on TG-induced Ca 2ϩ influx in human platelets and concluded that capacitative Ca 2ϩ influx is resistant to NO. The data presented here demonstrate that NO, indeed, is a potent inhibitor of capacitative cation influx in human platelets and that SERCA activity is required for this effect. This finding is consistent with the idea that NO inhibits capacitative cation influx indirectly by promoting SERCA-dependent refilling of intracellular Ca 2ϩ stores.
Abstract-Nitric oxide (NO) is a potent inhibitor of thrombin-induced increase in cytoplasmic free Ca 2ϩ concentration and aggregation in platelets, but the precise mechanism of this inhibition is unclear. To measure Ca 2ϩ /Mn 2ϩ influx in intact platelets and to monitor Ca 2ϩ uptake into the stores in permeabilized platelets, fura-2 was used. In intact platelets, maximal capacitative Ca 2ϩ and Mn 2ϩ influx developed rapidly (within 30 s) after fast release of Ca 2ϩ from the stores with thrombin (0.5 U/mL) or slowly (within 5 to 10 minutes) following passive Ca 2ϩ leak caused by inhibition of sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPase (SERCA) with 30 mol/L 2,5-di-(tert-butyl)-1,4-benzohydroquinone (BHQ). NO (1 mol/L) inhibited capacitative Ca 2ϩ and Mn 2ϩ influx independently of the time after thrombin application. In contrast, the effect of NO on BHQ-induced Ca 2ϩ and Mn 2ϩ influx was observed only during the first few minutes after BHQ application and completely disappeared when capacitative cation influx reached its maximum. In Ca 2ϩ -free medium, NO reduced the peak Ca 2ϩ rise caused by thrombin and significantly promoted Ca 1 Thrombin activates phospholipase C, which generates inositol-1,4,5-trisphosphate (IP 3 ) and leads to the rapid depletion of IP 3 -sensitive Ca 2ϩ stores 2, 3 and initiation of cation influx. 4 -6 Similar to other types of nonexcitable cells, 7 agonist-activated Ca 2ϩ influx in platelets is thought to be capacitative in nature, being also activated by passive store depletion with an inhibitor(s) of sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPase (SERCA), thapsigargin (TG) or 2,5-di-(tert-butyl)-1,4-benzohydroquinone (BHQ). 8 -11 Nitric oxide (NO), a potent inhibitor of thrombin-activated platelet aggregation, 12, 13 is known to decrease Ca 2ϩ cyt that is raised by agonists, 14 although the mechanism is not well defined. It has been shown that NO inhibits thrombin-and IP 3 -stimulated Ca 2ϩ release from internal stores in intact 15 and permeabilized platelets. 16, 17 However, it is still unclear whether NO also inhibits capacitative cation influx. Brune et al 17 found a significant inhibitory effect of the NO donor, sodium nitroprusside, on Mn 2ϩ influx in TG-treated platelets. In contrast, Okamoto et al 18 did not find an effect of the NO donor on TG-induced Ca 2ϩ influx in human platelets and concluded that capacitative Ca 2ϩ influx is resistant to NO. The data presented here demonstrate that NO, indeed, is a potent inhibitor of capacitative cation influx in human platelets and that SERCA activity is required for this effect. This finding is consistent with the idea that NO inhibits capacitative cation influx indirectly by promoting SERCA-dependent refilling of intracellular Ca 2ϩ stores.
Materials and Methods

Platelet Isolation Procedure
Blood from healthy adult volunteers was drawn into plastic nonsterile tubes containing 10% volume of anticoagulant. The composition of anticoagulant was (in g/100 mL): trisodium citrate 2.5, citric acid 1.5, and glucose 2.0. To obtain platelet-rich plasma (PRP), the anticoagulated blood was centrifuged for 10 minutes at 350g at room temperature. Aspirin (100 mol/L) was added to PRP to inhibit the activation of the platelets by thromboxane A 2 . Platelets were used within 5 hours after preparation. For experiments on permeabilized platelets, cells were obtained by gel filtration as follows. Prewashed Sepharose-2B gel (Sigma) was placed into the plastic column with the 70-m nylon mesh attached to the bottom and equilibrated with a 3ϫ volume of standard HEPES buffer of the following composition (in mmol/L): NaCl 137, KCl 2.7, MgCl 2 ⅐ 6H 2 O 1, NaH 2 PO 4 3.3, glucose 5.5, and HEPES 3.8 (pH 7.4). Ca 2ϩ was not added to the buffer, but its residual concentration was 1 to 3 mol/L as measured by Ca 2ϩ -sensitive electrode. Buffer was supplemented with 100 mol/L aspirin and 6 mU/mL apyrase to prevent platelet activation with thromboxane A 2 and traces of ADP, respectively. After collection, the platelet suspension was stored at 37°C and used during the next 3 to 4 hours. The cell number in the suspension used for experiments was 2 to 2.5ϫ10 8 /mL.
Fluorescence Measurements
The fluorescent probe fura-2 19 was used to monitor changes in Ca 2ϩ cyt in platelets. PRP was diluted with standard buffer to the final cell number of Ϸ10 8 /mL and centrifuged at 750g for 10 minutes. Platelets were resuspended in the same buffer containing 2.5 mol/L fura-2/AM and incubated at 37°C for 10 minutes. The platelet suspension was then centrifuged at 750g for 10 minutes and resuspended in 2 mL of buffer immediately before the fluorescence measurements. Cells were loaded with fura-2 before each run. Each experiment was done with 6 to 8ϫ10 7 cells/mL. Fluorescence (F) measurements were carried out at 37°C using a spectrofluorimeter (Hitachi F-4500) with excitation wavelength alternating between 340 and 380 nm every 0.5 s and emission wavelength 510 nm. Changes in Ca 2ϩ cyt were estimated from the F 340 /F 380 ratio (R 340/380 ). Data collection, ratio calculation, and analysis were performed with the Hitachi software. All the recordings were corrected for the cell autofluorescence determined in unloaded platelets. In some experiments the initial rate of fall in Ca 2ϩ concentration caused by NO in thrombin-stimulated platelets, and after addition of IP 3 or Ca 2ϩ in permeabilized platelets, was estimated from the initial slope during the first 5 to 20 seconds. Importantly, control experiments showed no evidence for a direct effect of NO either on response of fura-2 to Ca 2ϩ or on the fluorescence properties of fura-2. To study cation influx, Mn 2ϩ (100 to 300 mol/L) was added to the platelets suspended in standard buffer, and the rate of fura-2 quenching at an excitation and emission wavelength of 360 and 510 nm, respectively, was determined. The rate of Mn 2ϩ influx was estimated from the slope during the first 60 s after Mn 2ϩ addition, and the linear fit was performed with Microcal Origin software.
Experiments on Permeabilized Cells
Before the experiment, platelets were resuspended in an artificial cytoplasmic solution containing (in mmol/L): KCl 110, NaCl 10, KH 2 PO 4 1, KH 2 CO 3 5, and HEPES 20 (pH 7.1) and supplemented with 1 g/mL oligomycin, 2 g/mL antimycin, 2 mmol/L MgATP, and an ATP-regenerating system containing 5 mmol/L creatine phosphate and 15 U/mL creatine kinase. There was no Ca 2ϩ added, and its residual concentration in the cytoplasmic solution was 1 to 3 mol/L (as measured by a Ca 2ϩ -sensitive electrode). Fura-2 (K ϩ salt, 1 mol/L) was added to this solution to monitor the changes in free Ca 2ϩ . During the experiment 20 g/mL saponin was applied directly to the recording chamber, causing permeabilization of the platelet plasma membrane and resulting in sequestration of external Ca 2ϩ into the stores, lowering the free Ca 2ϩ concentration (see Figure  7A ). After 4 to 6 minutes, Ca 2ϩ concentration stabilized at a level of 200 to 250 nmol/L as calculated from the ratio F 340 /F 380 assuming a K d for fura-2 of 224 nmol/L. 19 
NO Solution
A standard 1-L intravenous bag was filled with distilled water (750 mL) that had been bubbled with nitrogen gas to remove oxygen.
Approximately 30 mEq of Bio-Rad analytical-grade anion exchange resin was mixed in the water before the bag was filled. The resin retains any nitrites or nitrates that may be formed by the reaction of NO with oxygen. The contents of the bag were bubbled with nitrogen gas for another 30 minutes. The contents were then mixed thoroughly, and the bag was placed in a refrigerator at 4°C. The concentration of NO in the solution equilibrated to give a 3.1Ϯ0.6 mmol/L (nϭ5) saturated solution that was stable at least for 1 week as measured by a chemiluminescent nitric oxide analyzer (Sievers NOA model 270). The absence of contaminating nitrite in saturated NO solution was confirmed by obtaining a similar analysis in the presence and absence of a reducing agent in the reflux chamber of the analyzer (KI in glacial acetic acid). At the time of the experiment, subsequent dilutions were made from the saturated NO solution by drawing off the solution from the bag with a gas-tight syringe and dissolving it in sealed tubes filled with deoxygenated solution (bubbled with nitrogen for 1 hour).
Materials
NO gas was from Matheson. Fura-2/AM and fura-2 (K ϩ salt) were from Molecular Probes. BHQ and IP 3 were from Calbiochem. All other drugs were from Sigma.
Statistical Analysis
Each experiment was repeated 3 to 9 times. ANOVA and paired t test were used to determine the statistical significance of differences in obtained data. PϽ0.05 was considered significant. The results on the bar graphs are expressed as meanϮSE.
Results
Cation Influx in Human Platelets Depends on Ca
2؉
Store Emptying
Although the existence of capacitative cation influx in platelets is widely accepted, the only strong evidence for it is the fact that TG and BHQ, inhibitors of SERCA that have been shown to deplete Ca 2ϩ stores without elevation of IP 3 , 20 cause a sustained Ca 2ϩ influx 8 -11 similar to that activated by thrombin. 4 -6 To study the effect of NO on capacitative cation influx, the time-dependent relationship between Ca 2ϩ store emptying and cation influx was first determined. For this purpose, cation influx after the rapid store emptying caused by thrombin was compared with the influx induced by the slower store emptying caused by inhibition of backsequestration into the stores by BHQ.
Thrombin-Induced Cation Influx
To experimentally separate intracellular Ca 2ϩ release from cation influx from the extracellular space, thrombin was applied at a submaximal concentration (0.5 U/mL) to suspensions of fura-2-loaded platelets in Ca 2ϩ -free medium. Cation influx was then analyzed following the addition of Ca 
BHQ-Induced Cation Influx
In Ca 2ϩ -free medium, BHQ caused a slower, smaller, and more sustained increase in Ca 2ϩ cyt ( Figure 3B ) compared with that of thrombin. Subsequent addition of external Ca 2ϩ caused a rapid increase in Ca 2ϩ cyt which, after reaching a peak, declined to a steady-state level ( Figure 3A and 3B). Unlike the thrombin-activated Ca 2ϩ influx, the amplitude of the BHQ-induced Ca 2ϩ influx increased with time following application of BHQ ( Figures 2B and 3) , reaching a maximum after 5 to 10 minutes.
As with Ca 2ϩ influx, BHQ-induced Mn 2ϩ influx increased during the period between the addition of BHQ and Mn 2ϩ , being negligible during the first 30 s and reaching a maximum in 5 minutes. Figure 2D summarizes the relationship between the length of the period between addition of BHQ and Mn 2ϩ and the rate of influx.
Effect of NO on Thrombin-and BHQ-Activated Ca 2؉ and Mn 2؉ Influx
To determine whether authentic NO has an inhibitory effect on capacitative cation influx in human platelets, NO was applied 30 s before addition of Ca 2ϩ or Mn 2ϩ in platelets stimulated with thrombin or BHQ. When added after thrombin-induced Ca 2ϩ mobilization had reached the peak, NO (1 mol/L) significantly increased the initial rate of decline in Ca 2ϩ cyt (from 0.007Ϯ0.002 ratio units/s before NO addition to 0.088Ϯ0.004 ratio units/s after NO addition; nϭ6, PϽ0.001) ( Figure 1A ; see also Figure 4C ) and profoundly inhibited the subsequent Ca 2ϩ rise and Mn 2ϩ influx ( Figure 1 ). The effect of NO did not depend on the Figure 1A and 1B). When NOcontaining solution was exposed to the air for 1 hour and then applied to platelets, it produced no effect on Ca 2ϩ cyt (not shown, nϭ3), indicating that NO, rather than the products of its degradation, was the active inhibitor of thrombin-induced cation influx. Contrary to that induced by thrombin, the influx of Ca 2ϩ and Mn 2ϩ induced by BHQ was affected by NO only during the first few minutes of BHQ treatment ( Figure 3A and 3C) . Summary data are shown in Figure 2B and 2D. However, after pretreatment of platelets with BHQ for 5 to 10 minutes, NO did not affect the subsequent Ca 2ϩ and Mn 2ϩ influx (Figures 2B and 2D and 3B and 3D) significantly. These results illustrate the time-dependent disappearance of the effect of NO on capacitative cation influx during the progressive inhibition of SERCA by BHQ. This points to the importance of SERCA-dependent store refilling for NOinduced inhibition of influx.
NO Increases the Amount of Ca 2؉ Released by Ionomycin in Thrombin-Activated Platelets
We conducted the following experiments to determine whether NO affects Ca 2ϩ stores in thrombin-activated platelets. Figure 4 shows thrombin-induced Ca 2ϩ release in the absence of extracellular Ca 2ϩ . Five minutes after thrombin application, ionomycin (2 mol/L) was applied to release the remaining portion of Ca 2ϩ from the stores. When ionomycin was applied after thrombin, it caused a 2.5 times smaller rise in Ca 2ϩ cyt than when it was applied alone to unstimulated platelets ( Figure 4A ; peak ⌬R 340/380 was 1.4Ϯ0.1 versus 3.5Ϯ0.3 ratio units, respectively; nϭ4, PϽ0.005). This indicates that after release from the stores by thrombin, Ca 2ϩ is taken up into the stores and is also extruded from the cells. To test whether NO can increase the amount of Ca 2ϩ in the stores after they were emptied by thrombin, NO (1 mol/L) was added at different times before or after the agonist. When NO was applied 30 s before thrombin ( Figure 4B ), the amplitude of the thrombin response was slightly suppressed (peak ⌬R 340/380 was 1.0Ϯ0. Figure 4C ). When NO was applied 30 s before ionomycin, it did not significantly increase the amplitude of Ca 2ϩ release by ionomycin (peak ⌬R 340/380 was 1.5Ϯ0.1 ratio units; nϭ4, PϾ0.05; Figure 4D ).
These results suggest that after Ca 2ϩ is released from the stores by thrombin, NO can promote its uptake into the stores, which can be a result of acceleration of Ca 2ϩ backsequestration or, alternatively, inhibition of Ca 2ϩ release. To discriminate between these possibilities, the following experiments were performed.
Inhibition of SERCA Abolishes the Effect of NO on Thrombin-Induced Ca 2؉ Release
In Ca 2ϩ -free medium, thrombin (0.5 U/mL) caused a fast Ca 2ϩ rise resulting from Ca 2ϩ release from the stores, followed by a slower Ca 2ϩ decline as a result of its uptake into the stores and extrusion from the cell ( Figure 5A 
Inhibition of Mitochondria Does Not Prevent the Effect of NO on Ca
2؉ cyt
By taking up Ca 2ϩ during agonist-induced activation, mitochondria could be involved in the regulation of capacitative Ca 2ϩ influx in different types of cells. [21] [22] [23] Inhibitors of mitochondrial metabolism were therefore used to determine whether mitochondria are involved in the inhibition of the thrombin-induced Ca 2ϩ rise in intact platelets caused by NO. Figures 6A and 6B illustrate the effect of NO on thrombinactivated Ca 2ϩ release and influx under control conditions ( Figure 6A ) and in the presence of the mitochondrial inhibitors ( Figure 6B ) oligomycin (1 g/mL) and antimycin (2 g/mL). As in the data obtained in the Jurkat cell line, 24 inhibition of mitochondria decreased the amplitude of thrombin-induced Ca 2ϩ rise (from 1.8Ϯ0.2 to 1.4Ϯ0.1; nϭ3, PϽ0.05). However, the inhibition by NO of the thrombininitiated Ca 2ϩ release and influx was unchanged. These results indicate that uptake of Ca 2ϩ into mitochondria is not involved in the inhibitory effect of NO on Ca 2ϩ cyt in platelets. , H-(1,2,4)  Oxadiazolo(4,3-a) Quinoxallin-1-one (ODQ To evaluate the role of cGMP formation in the effect of NO on Ca 2ϩ influx, specific guanylate cyclase inhibitor, ODQ, 25, 26 was used. At the concentration used in these experiments, ODQ has been shown to completely prevent the NO-induced cGMP rise in platelets. 27 The effect of NO (1 mol/L) on the rate of Ca 2ϩ removal from the cytoplasm and on Ca 2ϩ influx was compared in control platelets (preincubated with the vehicle, 0.1% DMSO) and in the platelets preincubated with ODQ (10 mol/L) for 1 hour ( Figure 6C and 6D). Pretreatment with ODQ did not alter the kinetics of the Ca 2ϩ -release phase or amplitude of the maximal Ca 2ϩ influx following platelet stimulation with thrombin. However, it resulted in a small but significant attenuation of the inhibitory effect of NO on the Ca 2ϩ increase associated with Ca 2ϩ influx. The rates of the NO-induced acceleration of the falling phase of Ca 2ϩ transient in control and ODQ-pretreated platelets were 0.051Ϯ0.003 ratio units/s and 0.039Ϯ0.003, respectively (nϭ5, PϽ0.05), which corresponds to a 24% decrease. The amplitude of the thrombin-induced Ca 2ϩ influx phase was inhibited by NO by 82% in the cells preincubated with vehicle (1.46Ϯ0.17 ratio units versus 0.26Ϯ0.02; nϭ5, PϽ0.01) and only by 67% in ODQ-treated cells (1.44Ϯ0.16 ratio units versus 0.47Ϯ0.06; nϭ5, PϽ0.01). Thus, the effect of NO (1 mol/L) on Ca 2ϩ influx in platelets is partially mediated by cGMP formation. These experiments also indicate the possible existence of another, cGMP-independent mechanism of NO-induced inhibition of capacitative cation influx in platelets.
Inhibitor of cGMP Production
NO Accelerates Ca 2؉ Uptake by the Stores in Permeabilized Platelets
To directly monitor the process of filling and emptying of internal Ca 2ϩ stores and to eliminate the involvement of the IP 3 cascade and plasma membrane-associated regulatory proteins (plasma membrane Ca 2ϩ -ATPase [PMCA] or Na ϩ /Ca 2ϩ exchanger), the free-Ca 2ϩ level was measured in suspensions of permeabilized platelets. Addition of saponin (20 g/mL) to the platelets resuspended in cytoplasmic solution caused an immediate decrease in free Ca 2ϩ ( Figure 7A ), which was completely prevented by BHQ (30 mol/L) added 2 minutes before saponin (not shown). In the presence of 2 mmol/L ATP, cytoplasmic Ca 2ϩ decreased from 1 to 3 mol/L to a stable level or set point 28 rise and uptake after exogenously added Ca 2ϩ ( Figure 7B ), indicating that these processes do not involve IP 3 -sensitive channels.
NO (1 mol/L) significantly increased the rate of Ca 2ϩ uptake after IP 3 -induced release (0.077Ϯ0.006 versus 0.024Ϯ0.003 ratio units/s in control; nϭ5, PϽ0.001; Figure  7C ), but it had no effect if applied after BHQ ( Figure 7D ). Because the effect of NO on IP 3 -induced Ca 2ϩ release could be due either to inhibition of IP 3 -induced Ca 2ϩ release or to acceleration of uptake into the stores, the effect of NO on Ca 2ϩ sequestration in the absence of IP 3 was determined. Exogenous Ca 2ϩ was added to the suspension of platelets after the cells were permeabilized and the set point was allowed to reestablish. The rate of uptake of exogenously added Ca 2ϩ , as well as the lowest free-Ca 2ϩ level reached after Ca 2ϩ addition and uptake, was highly dependent on the ATP concentration ( Figure 8A and 8B) . When added 30 s before Ca 2ϩ , NO significantly accelerated the rate of Ca 2ϩ sequestration into the stores ( Figure 8C) . However, the effect of NO was strongly dependent on the rate of sequestration observed in the absence of NO, which, in turn, depended on ATP concentration ( Figure 8C and 8D ). For example, at the higher rate of Ca 2ϩ uptake typical for 2 mmol/L ATP ( Figure 8B ), there was no effect of NO ( Figure 8D ; 0.042Ϯ0.005 ratio units/s under control conditions and 0.044Ϯ0.006 ratio units/s in the presence of NO; nϭ4, PϾ0.1). However, at lower ATP concentrations (100 to 200 mol/L ATP), NO significantly accelerated Ca 2ϩ uptake ( Figure 8C ), but this was observed only in those experiments in which the control rate was lower than 0.03 ratio units/s ( Figure 8E ). For these experiments, NO significantly increased the rate of Ca 2ϩ uptake into the stores from 0.015Ϯ0.003 in control to 0.022Ϯ0.003 ratio units/s in the presence of NO (nϭ7, PϽ0.05), representing an average 47% increase. Figure 8E summarizes the dependence of the effect of NO on the control rate of Ca 2ϩ uptake measured in platelets from different platelet donors at 3 different ATP concentrations (100 mol/L, 200 mol/L, and 2 mmol/L). At low concen- trations of ATP, when only part of the added Ca 2ϩ was taken into the stores ( Figure 8A and 8B) , NO also increased the percentage of Ca 2ϩ uptake from 49Ϯ11 to 68Ϯ8 (nϭ7, PϽ0.01). Thus, NO was able to increase the rate and quantity of Ca 2ϩ uptake into the stores, but only when the uptake was submaximal under our experimental conditions.
Discussion
Recently, we showed that NO indirectly inhibits storeoperated cation influx in vascular smooth muscle cells and proposed a hypothesis that this inhibition is a result of NO-induced acceleration of Ca 2ϩ back-sequestration into the stores. 32 Here we tested this idea in human platelets and provided new evidence showing that NO inhibits capacitative cation influx by accelerating the refilling of the stores, predominantly through increased SERCA-dependent Ca 2ϩ uptake.
Nonselective Cation Influx in Platelets Depends on the Stores
Our data are consistent with a close correlation of cation influx in human platelets with the filling state of the stores. 4 -6 Thrombin causes a fast release of Ca 2ϩ from IP 3 -sensitive Ca 2ϩ stores in platelets, which is followed by partial backsequestration into the stores and Ca 2ϩ extrusion from cells via PMCA and Na ϩ /Ca 2ϩ exchanger. 33 Under our experimental conditions Ca 2ϩ and Mn 2ϩ influx is maximally activated during the first 30 s after thrombin application and then gradually decreases. This decrease most probably results from the time-dependent partial back-sequestration of Ca 2ϩ into the stores. However, we cannot rule out the involvement of other possible reasons, including desensitization of the thrombin receptor signaling cascade or inactivation of plasma membrane cation channels.
When Ca 2ϩ was released slowly with BHQ (as was seen to occur in permeabilized platelets in Figure 7D ), the amplitude of Ca 2ϩ influx as well as the rate of Mn 2ϩ influx increased gradually with time, reaching a maximum after 5 minutes ( Figure 2B and 2D) . The absence of back-sequestration of Ca 2ϩ in the presence of BHQ might explain why the maximal amplitude of the BHQ-induced Ca 2ϩ rise was Ϸ2.5 times higher than that induced by thrombin (Figure 2A and 2B) . The rates of Mn 2ϩ influx in thrombin-and BHQ-treated platelets were comparable ( Figure 2C and 2D) , suggesting that SERCA-dependent Ca 2ϩ back-sequestration into the stores in the presence of thrombin, which is absent in BHQ-treated cells, can effectively reduce Ca 2ϩ influx. Thus, the maximal Ca 2ϩ and Mn 2ϩ influx in platelets coincides with the maximal emptying of the stores, consistent with a mechanism of capacitative cation influx.
NO Inhibits Capacitative Cation Influx in Human Platelets, but SERCA-Dependent Store Refilling Is Required
Our data indicate that SERCA-dependent refilling of the stores is required for NO to inhibit Ca 2ϩ and Mn 2ϩ influx. When Ca 2ϩ /Mn 2ϩ influx was activated by thrombin, NO was very effective and blocked this influx almost completely and independently of the time after thrombin application ( Figures   1 and 2) . In BHQ-treated platelets, however, NO was able to partially inhibit Ca 2ϩ and Mn 2ϩ influx and the rise in Ca 2ϩ cyt only during the first few minutes after BHQ application. During this initial phase, presumably, SERCA is only partially inhibited and some back-sequestration of Ca 2ϩ into the stores can still occur. After 5 to 10 minutes, when the process of SERCA inhibition by BHQ is apparently complete and maximal cation influx has developed (Figure 2) , the inhibitory effect of NO on Ca 2ϩ cyt disappears. The absence of the inhibitory effect of NO on maximum Ca 2ϩ and Mn 2ϩ influx after a 10-minute treatment with BHQ suggests that NO does not have a direct effect on plasma membrane cation channels, which are responsible for such influx.
The time-dependent loss of the effect of NO on cation influx demonstrated in the presence of the SERCA inhibitor could explain why some researchers 18, 34 failed to detect the inhibition of TG-induced cation influx in platelets by NO donors, while others 17 reported such an inhibition. The variability in the effect of NO could be also related to the incomplete inhibition of all SERCA isoforms by TG under different experimental conditions or to the differences between BHQ-and TG-sensitive Ca 2ϩ stores and their role in the regulation of cation channels.
NO Promotes SERCA-Dependent Back-Sequestration of Ca 2؉ Into the Stores
The absence of an effect of NO on capacitative cation influx when SERCA is inhibited shows that NO does not inhibit the influx directly and suggests the importance of functional SERCA for the NO-induced inhibition of cation influx. To determine whether NO indeed can accelerate the refilling of Ca 2ϩ stores in a SERCA-dependent manner, the following 2 approaches were used. In the first approach, ionomycin was used at a high concentration to release Ca 2ϩ from all the stores to determine whether NO can promote the refilling of the stores emptied by thrombin. In thrombin-activated platelets, NO was shown to significantly increase the total intracellular Ca 2ϩ pool released by ionomycin. The effect of NO was maximal if it was added before initiation of Ca 2ϩ release by thrombin, apparently because it promotes back-sequestration of Ca 2ϩ released by IP 3 . When NO was added later, most of the released Ca 2ϩ was already removed from the cytoplasm, which explains the insignificant increase in the Ca 2ϩ stores (Figure 4) .
Permeabilized platelets were used in the second approach, which allows direct observations of the Ca 2ϩ movements in and out of intracellular stores. Using this method, NO was found to accelerate uptake of Ca 2ϩ either after it was released from the stores with IP 3 or after exogenous Ca 2ϩ was added (Figure 8 ). The effect of NO disappeared in the presence of BHQ. The strong dependence on ATP concentration of Ca 2ϩ uptake in permeabilized platelets (Figure 8 ) points to the involvement of an ATP-using process, which, most logically, is SERCA. Importantly, the effect of NO strongly depends on the initial rate of Ca 2ϩ uptake (Figure 8 ). At a maximal rate of Ca 2ϩ sequestration, the possibility of a further increase of SERCA activity by NO is unlikely. Under physiological conditions, one would expect SERCA to work at a lower, submaximal rate that would allow its further acceleration by
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NO. In permeabilized platelets, NO had a stimulatory effect only when the rate of Ca 2ϩ uptake was experimentally decreased (by decreasing the concentration of ATP) ( Figure  8C and 8E). These results provide a possible explanation of the fact that some investigators did not observe an effect of NO on SERCA. 35 Indeed, SERCA activity is usually measured under experimental conditions providing its highest activity (at high Ca 2ϩ and/or ATP concentrations), which might exclude its further acceleration by NO. 14, 16 which theoretically can be mediated through NO-induced inhibition of IP 3 production by phospholipase C or suppression of IP 3 -induced Ca 2ϩ release, on one hand, and a rapid acceleration of Ca 2ϩ back-sequestration into the stores, on the other hand.
Role of IP
Although we cannot completely exclude an effect of NO exerted by changes in the production or action of IP 3 , there are several reasons why back-sequestration of Ca 2ϩ into the stores by SERCA appears to be the major physiological mechanism for the NO-induced decrease in Ca PMCA and Na ϩ /Ca 2ϩ exchanger have been proposed to be targets for NO action in other cells (for review, see Reference 36) . In human platelets, we found no evidence for a significant role of these Ca 2ϩ -removal mechanisms in the effects of NO. Indeed, when SERCA was inhibited by BHQ, Ca 2ϩ (released by thrombin) was successfully removed from the cytoplasm ( Figure 5 ), pointing to the activity of PMCA, Na ϩ /Ca 2ϩ exchanger, or both. However, NO did not affect Ca 2ϩ removal when SERCA was inhibited. Also, there was no effect of NO on the peak Ca 2ϩ rise in BHQ-treated platelets, although such extrusion mechanisms as PMCA and Na ϩ /Ca 2ϩ exchanger are expected to work under these conditions. By taking up Ca 2ϩ during agonist-induced activation, mitochondria could be involved in the regulation of capacitative Ca 2ϩ influx in different types of cells. [21] [22] [23] Our experiments with mitochondrial inhibitors (Figure 6) show that the effect of NO on intracellular Ca 2ϩ does not depend on oxidative metabolism by, or Ca 2ϩ uptake into, mitochondria. Thus, IP 3 -induced Ca 2ϩ release, PMCA, Na ϩ -Ca 2ϩ exchanger, and mitochondria, although they are potential targets for NO, seem not to play an important role in the effects of NO on Ca 2ϩ cyt in human platelets.
Role of cGMP Production in the Effect of NO on Ca 2؉ Influx in Human Platelets
It is well known that NO 37 and NO donors 27, 38 stimulate cGMP production in human platelets leading to the activation of cGMP-dependent protein kinase and inhibition of agonistinduced Ca 2ϩ cyt rise and platelet aggregation. 37, 39 In rat aortic smooth muscle cells, this effect was partially attributed to the phosphorylation of the SERCA-regulatory protein phospholamban and thus the increased sensitivity of SERCA to Ca 2ϩ . 40 It is tempting to look for a similar explanation for the effect of NO in platelets. In fact, a phospholamban-like 22-kDa protein, thrombolamban, found in platelets, 41 has been shown to regulate the activity of Ca 2ϩ uptake by the ER vesicles. However, comparative analysis of phospholamban and thrombolamban revealed differences in their structural and physical properties, as well as in the mechanisms for activation of the respective Ca 2ϩ pumps. 42 Moreover, no phosphorylation of thrombolamban by sodium nitroprusside or cGMP analogs was found in platelets. 39, 43 Thus, it seems unlikely that cGMP-dependent stimulation of platelet SERCA by NO is mediated by thrombolamban.
Inhibition of guanylate cyclase by ODQ has been shown to eliminate the cGMP rise caused by NO donors and to prevent their effect on platelet aggregation. 27 However, there are some indications that cGMP might not account for all the effects of authentic NO on Ca 2ϩ cyt . It was shown recently that inhibition of cGMP production with ODQ suppresses, but does not eliminate, the effects of authentic NO on intracellular Ca 2ϩ in smooth muscle cells, 44 as well as the effect of the NO donor S-nitrosoglutathione in platelets. 45 Similarly, we found that pretreatment of human platelets with 10 mol/L ODQ for 1 hour only partially blocked the inhibitory effect of NO on capacitative Ca 2ϩ influx ( Figure 6 ). This result points to the possibility that along with a cGMP-dependent pathway there is also another, cGMP-independent mechanism of NO effect on Ca 2ϩ influx in human platelets. Indeed, direct NO-induced nitrosylation of critical thiols is known to be responsible for cGMP-independent effects of NO on some other proteins. 46 -48 Further studies of the effects of NO on SERCA need to be done to fully understand this physiologically important pathway for regulation of capacitative cation influx and intracellular Ca 2ϩ in platelets and other nonexcitable cells.
